PT Siwani Makmur Tbk (SIMA) Stock 2027: A High-Risk Turnaround Story or a Delisting Risk?
Published: October 30, 2025
Last Updated: October 7, 2026
Financial data and analysis reviewed as of October 7, 2026.
![]() |
| PT Siwani Makmur Tbk (SIMA) |
Worldreview1989 - For U.S. investors looking at Indonesian small-cap stocks, PT Siwani Makmur Tbk (IDX: SIMA) presents a very different proposition from a conventional value investment. SIMA operates in the plastics and packaging industry, but its investment case is dominated not by ordinary earnings growth, but by trading suspension, financial recovery, corporate restructuring, liquidity, and the risk of delisting.
That distinction is critical.
KSEI identifies SIMA as an active listed security under the plastics and packaging sector, with 442,589,871 shares outstanding and an ISIN of ID1000063902. KSEI data also shows that approximately 99.91% of the shares were already in scripless form as of October 5, 2026.
However, the more important issue for a 2027 investor is that SIMA has been under suspension since February 17, 2020. Bursa Indonesia has previously warned of the potential for delisting because of the prolonged suspension.
Check : Indonesia Stock Exchange Listed Companies Directory
SIMA at a Glance
| Item | Assessment |
|---|---|
| Company | PT Siwani Makmur Tbk |
| Ticker | SIMA |
| Exchange | Indonesia Stock Exchange |
| Industry | Plastics & Packaging |
| Shares outstanding | 442.59 million |
| Trading status | Long-term suspension |
| Current quoted price | Rp50 in available market-data sources |
| 2027 investment profile | Extremely speculative |
| Primary catalyst | Trading normalization / restructuring |
| Major risk | Delisting and inability to monetize investment |
| Suitable for conservative investors? | No |
The quoted Rp50 price should not be interpreted in the same way as the price of a normally traded stock. Market-data providers currently show SIMA at Rp50, but the stock has effectively lacked normal price discovery because of the long suspension.
What Would an American Investor Notice First?
A U.S. investor would probably approach SIMA with three questions:
Can the company restore normal operations?
Can the shares return to normal trading?
Can shareholders avoid a permanent loss caused by restructuring or delisting?
This is fundamentally different from asking whether SIMA is “cheap.”
A stock trading at Rp50 is not automatically undervalued if investors cannot freely trade it or if the underlying company has unresolved balance-sheet and corporate-governance issues.
This is one of the most important analytical distinctions surrounding SIMA.
The Biggest Red Flag: The Suspension
SIMA's suspension began on February 17, 2020.
Bursa Indonesia subsequently warned that the company could face delisting under the applicable exchange rules, particularly where a prolonged suspension is combined with inadequate indications of business recovery. A 2024 Bursa announcement specifically identified SIMA as a company with potential delisting risk and referenced the February 17, 2020 suspension.
For an American investor, this would resemble a special-situation security rather than an ordinary publicly traded equity.
The investment thesis therefore cannot simply be:
“The stock is Rp50, so the downside is limited.”
That assumption is dangerous.
The actual downside can include:
prolonged illiquidity;
inability to exit the position;
restructuring risk;
dilution;
changes in corporate ownership;
potential relisting requirements;
and potentially delisting.
Financial Analysis: The Problem Is Not Just Revenue
Available historical financial-ratio data shows a highly unstable profitability profile.
For example, the available 2025 data indicates a negative net margin, while the historical series shows significant fluctuations in operating and net profitability. The same dataset indicates that SIMA's 2025 ROE remained negative.
That means the investment case cannot be built around a conventional “earnings growth + multiple expansion” thesis.
Instead, the critical question is:
Can management convert the company's operating assets and business activities into sustainable positive free cash flow?
That is much more important than simply increasing reported revenue.
Historical profitability picture
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net margin | Positive | Negative | Negative |
| ROA | Positive | Positive | Positive but weak |
| ROE | Positive | Positive | Negative |
| Overall assessment | Recovery | Deterioration | Recovery still unproven |
The available 2025 profitability data should therefore be treated as a warning rather than evidence of a completed turnaround.
Asset Efficiency Is Another Concern
Available historical operating data shows asset turnover declining from approximately 0.95x in 2023 to 0.71x in 2024 and 0.65x in 2025.
This is an important analytical signal.
A manufacturing or packaging company needs to generate sufficient revenue from its asset base to cover:
raw materials;
labor;
utilities;
maintenance;
financing costs;
depreciation;
administrative expenses;
and working-capital requirements.
If asset turnover deteriorates while profitability remains weak, the company may have difficulty generating attractive returns on invested capital.
My interpretation
The problem with SIMA is therefore not simply:
“Is the company profitable?”
The better question is:
“Can the company's productive asset base generate enough economic profit to justify keeping the company listed?”
That is a much higher hurdle.
The Balance Sheet Requires Extreme Caution
Some market-data services currently report extremely weak balance-sheet ratios for SIMA, including a very high debt-to-equity ratio.
However, investors should be careful when using automatically calculated ratios for a company with a complicated historical financial position.
For a 2027 investment decision, investors should prioritize:
the latest audited financial statements;
current liabilities;
total debt;
accumulated losses;
negative equity, if any;
related-party balances;
going-concern disclosures;
cash position;
operating cash flow;
and any restructuring agreements.
These numbers matter much more than a simple P/E ratio.
Why P/E Is Almost Useless for SIMA
Traditional investors often begin with:
P/E = Share Price ÷ EPS
But SIMA's earnings profile makes this metric unreliable.
Available market data shows negative EPS and therefore a negative P/E-type valuation.
When earnings are negative, investors should shift toward:
1. Enterprise value
If meaningful debt and cash data become available, enterprise value can help determine what investors are actually paying for the operating business.
2. Asset value
For a distressed company, tangible assets can become more important than earnings.
3. Recovery value
The key question becomes:
How much value could shareholders retain if the business successfully restructures?
4. Going-concern value
If management restores profitable operations, the company could potentially be valued using normalized EBITDA or free cash flow.
This creates three very different valuation outcomes.
SIMA's 2027 Bull Case
The bullish case is not based on Indonesia's economic growth alone.
It requires a sequence of events.
Bull Case Scenario
Step 1 — Corporate recovery
SIMA successfully demonstrates that its underlying packaging operation can operate sustainably.
Step 2 — Financial restructuring
Debt and legacy financial problems are reorganized without destroying shareholder value.
Step 3 — Improved profitability
Gross margins stabilize and operating expenses become manageable.
Step 4 — Positive operating cash flow
The company generates cash rather than depending on external financing.
Step 5 — Trading normalization
The suspension issue is resolved and investors regain a meaningful mechanism for price discovery.
Step 6 — Market re-rating
Once the company has restored credibility, investors can begin valuing SIMA based on earnings, assets, or cash flow rather than speculation.
If all six conditions occur, SIMA could become a genuine turnaround story.
SIMA's Bear Case
The bear case is considerably simpler.
If the company fails to demonstrate sufficient recovery, the prolonged suspension remains a major obstacle.
Bursa's previous announcements make clear that prolonged suspension can contribute to delisting risk.
The bearish scenario therefore looks like this:
Weak operations → continued financial pressure → inability to normalize trading → prolonged suspension → increasing corporate action risk → potential delisting.
In this scenario, the apparent low share price does not provide meaningful protection.
That is why I would classify SIMA as a capital-preservation-unfriendly stock for conventional investors.
Indonesia's 2027 Macro Environment
The broader Indonesian economy provides some support for the operating-business case.
BPS reported that Indonesia's economy grew 5.29% year over year in Q2 2026, while first-half 2026 growth reached 5.45%.
More importantly for manufacturers, BPS reported an IKBM manufacturing index of 52.31 in Q2 2026, indicating expansion. New orders, output and inventory components were also in expansion territory.
Indonesia's trade environment also remained active. January-August 2026 exports reached US$193.64 billion, up 4.74% year over year, while non-oil-and-gas exports rose 5.48%.
These figures provide a supportive macroeconomic backdrop for Indonesian manufacturing.
But there is an important distinction:
A strong macroeconomic environment does not automatically fix a financially distressed company.
SIMA must first solve its company-specific problems.
Interest Rates Could Still Matter
Bank Indonesia raised the BI-Rate to 5.75% in June 2026, partly to strengthen rupiah stability and manage inflation risks.
For a highly leveraged or financially constrained company, higher financing costs can make restructuring more difficult.
Therefore, a 2027 SIMA recovery would benefit from:
lower financing costs;
stronger domestic demand;
stable raw-material prices;
improved working-capital management;
and better access to capital.
The opposite combination could severely weaken the turnaround case.
What U.S. Investors Should Learn From SIMA
An American investor evaluating SIMA should think less like a conventional growth investor and more like a distressed-equity investor.
The relevant questions are:
Business
Is the core packaging business economically viable?
Balance sheet
What is the company's actual net asset position?
Liquidity
Can the company meet short-term obligations?
Governance
Can management restore investor confidence?
Capital structure
Will existing shareholders be diluted?
Exchange status
What specific conditions must be satisfied for normal trading?
Delisting
What is the probability that shareholders ultimately face a delisting event?
These questions are much more important than whether the stock looks cheap at Rp50.
2027 Scenario Analysis
Because the available public information does not provide enough reliable forward financial data to justify a precise EPS target, a scenario framework is more appropriate than pretending to know a specific 2027 fair value.
| Scenario | Business Condition | Trading Status | Investor Interpretation |
|---|---|---|---|
| Bull | Successful turnaround | Trading normalized | High-risk recovery opportunity |
| Base | Gradual restructuring | Suspension remains unresolved | Speculative / watchlist |
| Bear | Financial deterioration | Delisting risk increases | Capital-loss scenario |
Bull Case
SIMA restores profitable operations, improves its capital structure, resolves the suspension issue and demonstrates sustainable cash generation.
Potential result: substantial re-rating from distressed status.
Base Case
The company remains operational but fails to achieve a decisive breakthrough in financial restructuring or exchange requirements.
Potential result: little meaningful value realization for ordinary shareholders.
Bear Case
Financial weakness persists and the company cannot demonstrate an adequate recovery path.
Potential result: severe loss of shareholder value and potentially delisting.
My Unique Analytical View: SIMA Is a "Binary Recovery Equity"
This is where SIMA becomes particularly interesting.
I would not categorize SIMA simply as a “cheap Indonesian stock.”
I would classify it as a:
Binary Recovery Equity
The stock's potential outcome is heavily dependent on a relatively small number of corporate events.
That creates an unusual risk/reward structure.
A conventional company might generate shareholder returns through:
Revenue growth → margin expansion → EPS growth → valuation expansion → shareholder return.
SIMA's potential path is different:
Corporate restructuring → operational recovery → financial normalization → suspension resolution → restored market liquidity → valuation discovery.
This makes SIMA much closer to a special situation than a conventional long-term compounder.
What Would Change My View to Bullish?
I would become substantially more constructive if SIMA demonstrated all or most of the following:
Audited financial statements showing improving equity;
Positive operating cash flow;
Sustainable gross and operating margins;
Reduced financial liabilities;
A credible restructuring plan;
Clear resolution of the suspension;
No destructive shareholder dilution;
Improved corporate disclosure;
Evidence of sustainable production;
A clear pathway away from delisting risk.
Without these developments, a low share price alone is insufficient.
What Should Investors Monitor During 2027?
Investors should monitor five categories.
1. Bursa Indonesia announcements
Watch for announcements concerning suspension, delisting, relisting and special monitoring.
2. Financial statements
Focus on cash flow and equity, not merely revenue.
3. Corporate actions
Rights issues, private placements, debt restructuring and changes in ownership can materially alter the investment thesis.
4. Business recovery
Revenue growth is only useful if it produces sustainable margins and cash flow.
5. Trading liquidity
A stock that cannot be freely traded cannot be evaluated using the same framework as a normal listed company.
SIMA 2027 Investment Verdict
For a conventional long-term investor, SIMA is currently too risky to classify as a normal value investment.
The company has a potentially interesting underlying industrial business, and Indonesia's manufacturing and economic environment remains relatively supportive. BPS reported continued economic expansion and manufacturing-sector expansion during 2026.
However, the company's prolonged suspension is the dominant investment variable.
The most important question for 2027 is therefore not:
“Can SIMA rise from Rp50?”
It is:
“Can SIMA restore a financially sustainable business and regain a viable position as a normally traded public company?”
Until there is convincing evidence of that recovery, SIMA should be treated as a high-risk special situation rather than a conventional buy-and-hold stock.
Overall 2027 Rating
Risk Level: Very High
Investment Style: Distressed / Special Situation
Fundamental Quality: Weak / Recovery Dependent
Liquidity: Extremely High Risk
Catalyst Potential: High if restructuring succeeds
Capital Preservation: Poor
2027 Outlook: Speculative / Watchlist
Bottom Line for U.S. Investors
An American investor may be attracted to SIMA because of its extremely low nominal share price and the possibility of a turnaround.
But the correct investment mindset is not:
“Cheap stock = high upside.”
It is:
“Distressed company + suspended security + possible corporate recovery = asymmetric but extremely high-risk special situation.”
The upside could be significant if SIMA successfully restores its business, financial condition and trading status.
The downside, however, is not simply a decline in the stock price.
The more serious risk is that shareholders may remain trapped in an illiquid security while the company's corporate and financial problems remain unresolved.
For 2027, SIMA is therefore a stock to monitor for evidence of recovery—not a stock where the current nominal price alone creates a convincing investment thesis.
Primary and Authority References
Indonesia Stock Exchange (IDX) — official listed-company disclosure and financial-report platform. Indonesia Stock Exchange — Listed Company Disclosure
KSEI — official securities registration data for PT Siwani Makmur Tbk, including ticker, ISIN and shares outstanding. KSEI — Siwani Makmur Tbk Securities Profile
BPS-Statistics Indonesia — official Q2 2026 economic growth data. BPS — Indonesia Q2 2026 Economic Growth
BPS-Statistics Indonesia — official manufacturing business-condition index for Q2 2026. BPS — Manufacturing Business Condition and Prospect Index Q2 2026
BPS-Statistics Indonesia — official August 2026 export and import data. BPS — Indonesia August 2026 Exports and Imports
Bank Indonesia — official June 2026 monetary-policy assessment. Bank Indonesia — June 2026 Monetary Policy Review
About the Author
Investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Alternative Assets
- Business & Startups
- Franchise
- Insurance
- Property and Real Estate
- Stocks
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks.


